Appointment of CFO

Cfo ResignedKmp ResignedManagement Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹17.76

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+4.7% vs market

Pharmaceuticals peers, median of 153sector+0.5%+4.5% vs sector

On the reaction day the stock moved 4.7 pts more than Nifty Microcap 250 and 4.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.0+0.2+4.7+0.5+4.5

Next day

+7.0+0.9+6.1+0.6+6.4

+8.8+0.4+8.5+0.3+8.6

+6.3-0.8+7.1-0.7+7.0

+3.9+0.2+3.7-0.7+4.5

+9.7+0.7+9.0-0.2+10.0

+12.5+1.2+11.3+0.2+12.3

15d

+5.6+2.0+3.6-0.2+5.8

+12.6+0.6+12.0-2.3+15.0

+61.6-4.2+65.8-5.4+67.0

+59.0-6.1+65.1-6.3+65.3

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kabra Drugs Ltd announced a change at the Chief Financial Officer position on 08th October 2025. Mr. Bangalore Venkatakrishnappa Ananth Kumar resigned as CFO and Key Managerial Personnel, effective the same day. Mr. T. Pavanasam, a Commerce Graduate with over 15 years of experience in finance, taxation, and allied laws across various industries, has been appointed as the new CFO and KMP, also effective 08th October 2025. The change was approved by the Board on the recommendation of the Nomination and Remuneration Committee and the Audit Committee.

Likely market impact

A routine CFO transition with both outgoing and incoming CFOs taking effect on the same day, suggesting a planned handover. Investors should watch for any further disclosures about the reasons behind the change, though no immediate material impact on operations or shareholder value is indicated.